Survival Benefits of Ganoderma Lucidum in Early-stage Triple-negative Breast Cancer: A Real World Study.
Baohong JiangNa LiWei DuLijun ZengYuanbin TangLunqi LuoHongbo ZhuFeng Ye
Published in: Recent patents on anti-cancer drug discovery (2024)
The results of this real-world propensity-score-matched study suggest that GLSP can improve OS and DFS in early-stage TNBC patients. A higher OS was observed for patients taking GLSP, particularly in stage II and stage III.